Relapsed or Refractory Non-Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch Relapsed or Refractory Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT03755154) | Institut de Recherches Internationales Servier | 2019-07-17 |
Track Relapsed or Refractory Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.